FBL and rheumatoid arthritis: Our ELISA data formally demonstrate that the CCP2 peptides commonly used in diagnostic ELISAs de facto act as surrogate antigens for the four most extensively studied ACPA fine specificities in RA: anti-CEP-1, anti-Cit-vim, anti-Cit-fib, and anti-Cit-C1 antibodies.